Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zynerba Pharmaceuticals

1.30
+0.0000
Volume:- -
Turnover:1.13M
Market Cap:65.60M
PE:-1.62
High:1.30
Open:1.30
Low:1.30
Close:1.30
Loading ...
OverviewCompanyNewsFilings
Jun 16, 2022

Major Issues Report

8-K - Current report
Jun 08, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jun 01, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 01, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 01, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 04, 2022

Major Issues Report

8-K - Current report
Nov 22, 2021

Major Issues Report

8-K - Current report
Nov 15, 2021

Major Issues Report

8-K - Current report
Nov 15, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 13, 2021

Major Issues Report

8-K - Current report
Sep 09, 2021

Major Issues Report

8-K - Current report
Sep 07, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2021

Major Issues Report

8-K - Current report
More

Analyst Rate

Hold
Buy
0.00%
Hold
100.00%
Sell
0.00%

Corporate Actions

Delist
Oct 12, 2023
Financial Report Announcement
Aug 14, 2023 Pre-Market
Financial Report Announcement
May 15, 2023 Pre-Market
Financial Report Announcement
Mar 28, 2023 Pre-Market
Financial Report Announcement
Aug 10, 2022 Pre-Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-1.71
Current
-2.91
Sector Average
72.04%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-1.71
Maximum
-0.44
+1 STD
-1.04
Minimum
-5.10
-1 STD
-4.78
Average
-2.91

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.